{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:32:25Z","timestamp":1787769145899,"version":"build-2784847793"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012043","name":"Kindai University","doi-asserted-by":"publisher","award":["KD2204"],"award-info":[{"award-number":["KD2204"]}],"id":[{"id":"10.13039\/100012043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21\\u202FK06978"],"award-info":[{"award-number":["21\\u202FK06978"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20\\u202FK07434"],"award-info":[{"award-number":["20\\u202FK07434"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22\\u202FK07034"],"award-info":[{"award-number":["22\\u202FK07034"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["A-178"],"award-info":[{"award-number":["A-178"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jconrel.2024.05.035","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T21:07:04Z","timestamp":1718140024000},"page":"603-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficient intracellular drug delivery by co-administration of two antibodies against cell adhesion molecule 1"],"prefix":"10.1016","volume":"371","author":[{"given":"Man","family":"Hagiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Yoneshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.05.035_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070674","article-title":"Impact of endocytosis mechanisms for the receptors targeted by the currently approved antibody-drug conjugates (ADCs)-a necessity for future ADC Research and Development","volume":"14","author":"Hammood","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/86934","article-title":"TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer","volume":"27","author":"Kuramochi","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0015","first-page":"1321","article-title":"IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function","volume":"18","author":"Watabe","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1349-7006.2005.00089.x","article-title":"Involvement of a cell adhesion molecule, TSLC1\/IGSF4, in human oncogenesis","volume":"96","author":"Murakami","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0025","doi-asserted-by":"crossref","first-page":"35421","DOI":"10.1074\/jbc.M305387200","article-title":"Implications of nectin-like molecule-2\/IGSF4\/RA175\/SgIGSF\/TSLC1\/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells","volume":"278","author":"Shingai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbrc.2009.10.088","article-title":"Tumor suppressor CADM1 is involved in epithelial cell structure","volume":"390","author":"Sakurai-Yageta","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082894","article-title":"Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg","volume":"9","author":"Murakami","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0040","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1126\/science.1072356","article-title":"SynCAM, a synaptic adhesion molecule that drives synapse assembly","volume":"297","author":"Biederer","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0045","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/emboj.2011.336","article-title":"Lateral assembly of the immunoglobulin protein SynCAM 1 controls its adhesive function and instructs synapse formation","volume":"30","author":"Fogel","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0050","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1523\/JNEUROSCI.2739-07.2007","article-title":"SynCAMs organize synapses through heterophilic adhesion","volume":"27","author":"Fogel","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0055","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood-2002-07-2265","article-title":"SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF","volume":"101","author":"Ito","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/labinvest.3700231","article-title":"Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts","volume":"85","author":"Koma","year":"2005","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0065","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.4049\/jimmunol.174.11.6934","article-title":"The spermatogenic Ig superfamily\/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves","volume":"174","author":"Furuno","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2012.05.016","article-title":"Cell adhesion molecule 1 (CADM1) on mast cells promotes interaction with dorsal root ganglion neurites by heterophilic binding to nectin-3","volume":"250","author":"Furuno","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0075","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1053\/j.gastro.2008.01.081","article-title":"Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions","volume":"134","author":"Koma","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061579","article-title":"CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells","volume":"8","author":"Moiseeva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0085","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/labinvest.2008.15","article-title":"Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium","volume":"88","author":"Ito","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.945007","article-title":"Possible therapeutic utility of anti-cell adhesion molecule 1 antibodies for malignant pleural mesothelioma","volume":"10","author":"Hagiyama","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1349-7006.2006.00163.x","article-title":"Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor","volume":"97","author":"Nakataki","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114123","article-title":"Cell adhesion molecule 1 contributes to cell survival in crowded epithelial monolayers","volume":"21","author":"Hagiyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bbrc.2020.05.103","article-title":"CADM1 suppresses c-Src activation by binding with Cbp on membrane lipid rafts and intervenes colon carcinogenesis","volume":"529","author":"Tsuboi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0110","article-title":"Functional and clinical characteristics of cell adhesion molecule CADM1 in Cancer","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0115","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.0812059106","article-title":"Persistent elimination of ErbB-2\/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis","volume":"106","author":"Ben-Kasus","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/cl.23967","article-title":"Search for inhibitors of endocytosis: intended specificity and unintended consequences","volume":"2","author":"Dutta","year":"2012","journal-title":"Cell Logist."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.113385","article-title":"Chemoenzymatic glycan labelling as a platform for site-specific IgM-antibody drug conjugates","volume":"584","author":"Moh","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S","article-title":"Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons","volume":"37","author":"Lang","year":"1998","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood.V97.4.1141","article-title":"Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts","volume":"97","author":"Salzer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.184093","article-title":"Refinement of singer-Nicolson fluid-mosaic model by microscopy imaging: lipid rafts and actin-induced membrane compartmentalization","volume":"1865","author":"Suzuki","year":"2023","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121908","article-title":"Super-resolution imaging of Fas\/CD95 reorganization induced by membrane-bound Fas ligand reveals nanoscale clustering upstream of FADD recruitment","volume":"11","author":"Frazzette","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0155","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/cbic.201500278","article-title":"Super-resolution imaging and quantitative analysis of membrane protein\/lipid raft clustering mediated by cell-surface self-assembly of hybrid Nanoconjugates","volume":"16","author":"Hartley","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024893118","article-title":"Cytokine receptor cluster size impacts its endocytosis and signaling","volume":"118","author":"Salavessa","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004721","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1\/TSLC1 for inactivation of the NF-kappaB inhibitor A20 and constitutive NF-kappaB signaling","volume":"11","author":"Pujari","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0170","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1131380","article-title":"TRAIL-receptor 1 IgM antibodies strongly induce apoptosis in human cancer cells in vitro and in vivo","volume":"5","author":"Piao","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0175","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-20-1132","article-title":"Multimeric anti-DR5 IgM agonist antibody IGM-8444 is a potent inducer of Cancer cell apoptosis and synergizes with chemotherapy and BCL-2 inhibitor ABT-199","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063414","article-title":"The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78","volume":"8","author":"Rasche","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0185","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1158\/1078-0432.CCR-15-3111","article-title":"A GRP78-directed monoclonal antibody recaptures response in refractory multiple myeloma with extramedullary involvement","volume":"22","author":"Rasche","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","article-title":"Considerations for the Design of Antibody-Based Therapeutics","volume":"109","author":"Goulet","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cei.13545","article-title":"Isotype selection for antibody-based cancer therapy","volume":"203","author":"Vukovic","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2020.11.121","article-title":"CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane","volume":"534","author":"Funaki","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1349-7006.2012.02277.x","article-title":"Expression of a splicing variant of the CADM1 specific to small cell lung cancer","volume":"103","author":"Kikuchi","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1078-0432.CCR-12-1139","article-title":"Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation","volume":"19","author":"Botling","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0215","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cncr.21800","article-title":"Hypermethylation of the TSLC1\/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma","volume":"106","author":"Kikuchi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0220","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/cncr.11599","article-title":"Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung","volume":"98","author":"Uchino","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0225","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1349-7006.2007.00480.x","article-title":"Expression and DNA methylation patterns of Tslc1 and dal-1 genes in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats","volume":"98","author":"Tsujiuchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0230","first-page":"1053","article-title":"Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation","volume":"25","author":"Zhang","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0235","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ijc.25356","article-title":"CADM1\/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease","volume":"128","author":"Chen","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0240","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2004.08.050","article-title":"IGSF4 promoter methylation and expression silencing in human cervical cancer","volume":"96","author":"Li","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0245","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.2367","article-title":"Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC","volume":"215","author":"Overmeer","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0250","first-page":"2047","article-title":"Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0255","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0260","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/leu.2011.379","article-title":"Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma","volume":"26","author":"Nakahata","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0265","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0270","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14712598.2017.1347634","article-title":"Mogamulizumab for the treatment of T-cell lymphoma","volume":"17","author":"Makita","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-16-1022","article-title":"Phase II study of Alemtuzumab (CAMPATH-1) in patients with HTLV-1-associated adult T-cell leukemia\/lymphoma","volume":"23","author":"Sharma","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"S. Horwitz, O.A. O'Connor, B. Pro, T. Illidge, M. Fanale, R. Advani, N.L. Bartlett, J.H. Christensen, F. Morschhauser, E. Domingo-Domenech, G. Rossi, W.S. Kim, T. Feldman, A. Lennard, D. Belada, A. Illes, K. Tobinai, K. Tsukasaki, S.P. Yeh, A. Shustov, A. Huttmann, K.J. Savage, S. Yuen, S. Iyer, P.L. Zinzani, Z. Hua, M. Little, S. Rao, J. Woolery, T. Manley, L. Trumper, E.-S. Group","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0285","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2017-12-821009","article-title":"Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas","volume":"131","author":"Fanale","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0290","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12185-020-02939-1","article-title":"Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia\/lymphoma","volume":"112","author":"Chilmi","year":"2020","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0295","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.26.9.3610-3624.2006","article-title":"Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1\/IGSF4, an immunoglobulin superfamily cell adhesion molecule","volume":"26","author":"Yamada","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0300","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/MCB.26.9.3595-3609.2006","article-title":"Loss of TSLC1 causes male infertility due to a defect at the spermatid stage of spermatogenesis","volume":"26","author":"van der Weyden","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0305","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.26.2.718-726.2006","article-title":"Oligo-astheno-teratozoospermia in mice lacking RA175\/TSLC1\/SynCAM\/IGSF4A, a cell adhesion molecule in the immunoglobulin superfamily","volume":"26","author":"Fujita","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0310","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1523\/JNEUROSCI.2736-20.2020","article-title":"Differential contribution of Cadm1-Cadm3 cell adhesion molecules to peripheral myelinated axons","volume":"41","author":"Sukhanov","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2024.05.035_bb0315","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1634\/theoncologist.2015-0276","volume":"21","author":"Gravanis","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2024.05.035_bb0320","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1078-0432.CCR-20-2275","article-title":"FDA approval summary: Enfortumab Vedotin for locally advanced or metastatic urothelial carcinoma","volume":"27","author":"Chang","year":"2021","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:44:23Z","timestamp":1777509863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":64,"alternative-id":["S0168365924003195"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.035","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient intracellular drug delivery by co-administration of two antibodies against cell adhesion molecule 1","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}